Patent details

EP2329848 Title: Lixisenatide as add-on therapy to insulin glargine and metformin for treating type 2 diabetes

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2329848
WO Application Number:
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP09175877.1
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Germany (DE)
Publications:

Dates

Filing date:
13/11/2009
Grant date:
24/10/2012
EP Publication Date:
08/06/2011
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
03/09/2017
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
24/10/2012
EP B1 Publication Date:
24/10/2012
EP B2 Publication Date:
19/06/2019
EP B3 Publication Date:
Description Translation B1 Received Date:
10/01/2013
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
12/11/2029
Lapsed By Expiration Date:
Patent Validated Date:
10/09/2019
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
24/10/2012
 
 

 

Name:
Sanofi-Aventis Deutschland GmbH
Address:
Brüningstraße 50, 65929 FRANKFURT AM MAIN, Germany (DE)

Agent

Name:
ir. W.J.J.M. Kempes
From:
09/09/2019
Address:
Dogio Patents Postbus 2350, 1200 CJ, Hilversum, Netherlands (NL)
To:

Inventor

1

Name:
Silvestre, Louise
Address:
75013 Paris, France (FR)

2

Name:
Souhami, Elisabeth
Address:
75013 Paris, France (FR)

3

Name:
Wei, Xiaodan
Address:
Bridgewater, NJ 08807, United States of America (US)

Classification

IPC or IDT classification:
A61K 31/155; A61K 38/26; A61K 38/28; A61K 45/06;

Publication

Bulletin

1

Bulletin Heading:
EP5
Journal edition number:
37/19
Publication date:
11/09/2019
Description:
European patents granted in amended form for the Netherlands in which an amended translation was filed ex Article 52 par. 6 of the NL Patent Law 1995

2

Bulletin Heading:
EP4
Journal edition number:
25/19
Publication date:
19/06/2019
Description:
European patents granted in amended form for the Netherlands

3

Bulletin Heading:
MED
Journal edition number:
25/19
Publication date:
19/06/2019
Description:
Other communications

4

Bulletin Heading:
VB1
Journal edition number:
2013/37
Publication date:
11/09/2013
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

5

Bulletin Heading:
EP3
Journal edition number:
2013/08
Publication date:
20/02/2013
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

6

Bulletin Heading:
EP2
Journal edition number:
2012/44
Publication date:
31/10/2012
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
201925
Publication date:
19/06/2019
Description:
Patent maintained (B2 publication)

2

Issue number:
201336
Publication date:
04/09/2013
Description:
Opposition procedure started

3

Issue number:
201243
Publication date:
24/10/2012
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
30/11/2026
Annual Fee Number:
18
Annual Fee Amount:
1200 Euro
Last Annual Payment Date:
12/09/2025
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
1100 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
09/09/2019 Outgoing Correspondence Letter no formal defects 1 PDF /7/7/8/5/7/0509175877/docs/ep09175877.1_1_298142l271.pdf
03/09/2019 Claims First filed claims 2 PDF /7/7/8/5/7/0509175877/docs/ep09175877.1_2_claims20190903171513797.pdf
10/01/2013 Incoming Correspondence Paper Other 1 PDF /7/7/8/5/7/0509175877/docs/ep09175877.1_0_incomingcorrespondencepaper20130110.pdf
10/01/2013 Claims Translated claims 2 PDF /7/7/8/5/7/0509175877/docs/ep09175877.1_3_claims20130110.pdf